The diabetes hyperglycemia Insulin is known to have a regulatory role on glucose levels and the anti-insulin antibodies are frequently responsible to block the insulin ligation to the respective receptor, increasing the biodisponibility of this hormone and decreasing its action [26–28], resulting from defects in insulin secretion, insulin action, or both [2], observed in diabetes. The gene discussed is INS; the disease is Hyperglycemia.